FdaApplication

NDA 020538

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANDOZ INC
application_typeNDA
approval_date1999-01-08

Products (9)

ProductActive ingredientStrengthDosage form
ESTRADIOLESTRADIOL0.1MG/24HRFilm, Extended Release;Transdermal
ESTRADIOLESTRADIOL0.0375MG/24HRFilm, Extended Release;Transdermal
ESTRADIOLESTRADIOL0.05MG/24HRFilm, Extended Release;Transdermal
ESTRADIOLESTRADIOL0.075MG/24HRFilm, Extended Release;Transdermal
VIVELLE-DOTESTRADIOL0.025MG/24HRSYSTEM;TRANSDERMAL
VIVELLE-DOTESTRADIOL0.1MG/24HRSYSTEM;TRANSDERMAL
VIVELLE-DOTESTRADIOL0.0375MG/24HRSYSTEM;TRANSDERMAL
VIVELLE-DOTESTRADIOL0.075MG/24HRSYSTEM;TRANSDERMAL
VIVELLE-DOTESTRADIOL0.05MG/24HRSYSTEM;TRANSDERMAL

9 products